1
|
Lancellotti P, Postolache A, Dulgheru R. Highlights of imaging heart structure and function. Acta Cardiol 2023; 78:383-386. [PMID: 37224023 DOI: 10.1080/00015385.2023.2206690] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Affiliation(s)
- Patrizio Lancellotti
- Department of Cardiology, CHU SartTilman, University of Liège Hospital, GIGA Cardiovascular Sciences, Liège, Belgium
- Gruppo Villa Maria Care and Research, Maria Cecilia Hospital, Cotignola, and Anthea Hospital, Bari, Italy
| | - Adriana Postolache
- Department of Cardiology, CHU SartTilman, University of Liège Hospital, GIGA Cardiovascular Sciences, Liège, Belgium
| | - Raluca Dulgheru
- Department of Cardiology, CHU SartTilman, University of Liège Hospital, GIGA Cardiovascular Sciences, Liège, Belgium
| |
Collapse
|
2
|
Neglia D, Liga R, Gimelli A, Podlesnikar T, Cvijić M, Pontone G, Miglioranza MH, Guaricci AI, Seitun S, Clemente A, Sumin A, Vitola J, Saraste A, Paunonen C, Sia CH, Paleev F, Sade LE, Zamorano JL, Maroz-Vadalazhskaya N, Anagnostopoulos C, Macedo F, Knuuti J, Edvardsen T, Cosyns B, Petersen SE, Magne J, Laroche C, Berlè C, Popescu BA, Delgado V. Use of cardiac imaging in chronic coronary syndromes: the EURECA Imaging registry. Eur Heart J 2023; 44:142-158. [PMID: 36452988 DOI: 10.1093/eurheartj/ehac640] [Citation(s) in RCA: 8] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/16/2021] [Revised: 09/20/2022] [Accepted: 10/26/2022] [Indexed: 12/05/2022] Open
Abstract
BACKGROUND The prospective, multicentre EURECA registry assessed the use of imaging and adoption of the European Society of Cardiology (ESC) Guidelines (GL) in patients with chronic coronary syndromes (CCS). METHODS Between May 2019 and March 2020, 5156 patients were recruited in 73 centres from 24 ESC member countries. The adoption of GL recommendations was evaluated according to clinical presentation and pre-test probability (PTP) of obstructive coronary artery disease (CAD). RESULTS The mean age of the population was 64 ± 11 years, 60% of patients were males, 42% had PTP >15%, 27% had previous CAD, and ejection fraction was <50% in 5%. Exercise ECG was performed in 32% of patients, stress imaging as the first choice in 40%, and computed tomography coronary angiography (CTCA) in 22%. Invasive coronary angiography (ICA) was the first or downstream test in 17% and 11%, respectively. Obstructive CAD was documented in 24% of patients, inducible ischaemia in 19%, and 13% of patients underwent revascularization. In 44% of patients, the overall diagnostic process did not adopt the GL. In these patients, referral to stress imaging (21% vs. 58%; P < 0.001) or CTCA (17% vs. 30%; P < 0.001) was less frequent, while exercise ECG (43% vs. 22%; P < 0.001) and ICA (48% vs. 15%; P < 0.001) were more frequently performed. The adoption of GL was associated with fewer ICA, higher proportion of diagnosis of obstructive CAD (60% vs. 39%, P < 0.001) and revascularization (54% vs. 37%, P < 0.001), higher quality of life, fewer additional testing, and longer times to late revascularization. CONCLUSIONS In patients with CCS, current clinical practice does not adopt GL recommendations on the use of diagnostic tests in a significant proportion of patients. When the diagnostic approach adopts GL recommendations, invasive procedures are less frequently used and the diagnostic yield and therapeutic utility are superior.
Collapse
Affiliation(s)
- Danilo Neglia
- Cardiovascular and Imaging Departments, Fondazione Toscana G. Monasterio, Via Giuseppe Moruzzi, 1, 56124 Pisa, Italy
- Sant'Anna School of Advanced Studies, Piazza Martiri della Libertà, 33, 56127 Pisa, Italy
| | - Riccardo Liga
- Dipartimento di Patologia Chirurgica, Medica, Molecolare e dell' Area Critica, University of Pisa, Via Savi 10, 56126 Pisa, Italy
- Dipartimento Cardiotoraco Vascolare, Azienda Ospedaliero-Universitaria Pisana, Via Paradisa, 2, 56124 Pisa, Italy
| | - Alessia Gimelli
- Cardiovascular and Imaging Departments, Fondazione Toscana G. Monasterio, Via Giuseppe Moruzzi, 1, 56124 Pisa, Italy
| | - Tomaž Podlesnikar
- Department of Cardiology, University Medical Centre Ljubljana, Zaloška cesta 2, 1000 Ljubljana, Slovenia
- Department of Cardiac Surgery, University Medical Centre Maribor, Ljubljanska ulica 5, 2000 Maribor, Slovenia
| | - Marta Cvijić
- Department of Cardiology, University Medical Centre Ljubljana, Zaloška cesta 2, 1000 Ljubljana, Slovenia
- Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia
| | - Gianluca Pontone
- Department of Perioperative Cardiology and Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS, Via Carlo Parea, 4, 20138 Milano, Italy
| | - Marcelo Haertel Miglioranza
- EcoHaertel-Mae de Deus Hospital, R. José de Alencar, 286 - Menino Deus, Porto Alegre - RS, 90880-481, Brazil
- Federal University of Health Sciences of Porto Alegre (UFCSPA), R. Sarmento Leite, 245 - Centro Histórico, Porto Alegre - RS, 90050-17, Brazil
- Institute of Cardiology-University Foundation of Cardiology, R. Sarmento Leite, 245 - Centro Histórico, Porto Alegre - RS, 90050-170, Brazil
| | - Andrea Igoren Guaricci
- Department of Emergency and Organ Transplantation, Institute of Cardiovascular Disease, University Hospital 'Policlinico' of Bari, Piazza Giulio Cesare, 11, 70124 Bari, Italy
| | - Sara Seitun
- Department of Radiology, IRCCS Policlinico San Martino Hospital, Largo Rosanna Benzi, 10, 16132 Genova, Italy
| | - Alberto Clemente
- Cardiovascular and Imaging Departments, Fondazione Toscana G. Monasterio, Via Giuseppe Moruzzi, 1, 56124 Pisa, Italy
| | - Alexey Sumin
- Federal State Budgetary Scientific Institution "Research Institute for Complex Issues of Cardiovascular Diseases", Sosnoviy Blvd., 6, 650002 Kemerovo, Russian Federation
| | - João Vitola
- Quanta Diagnostico por Imagem, R. Alm. Tamandaré, 1000 - Alto da XV, Curitiba - PR, 80045-170, Brazil
| | - Antti Saraste
- Heart Centre, Turku University Hospital and University of Turku, Kiinamyllynkatu 4-8, 20521 Turku, Finland
| | - Christian Paunonen
- Heart Centre, Turku University Hospital and University of Turku, Kiinamyllynkatu 4-8, 20521 Turku, Finland
| | - Ching-Hui Sia
- National University Heart Centre Singapore, 5 Lower Kent Ridge Rd, 119074 Singapore, Singapore
| | - Filipp Paleev
- National Medical Research Center of Cardiology, 3-Ya Cherepkovskaya Ulitsa, 15A, 121552 Moscow, Russian Federation
| | - Leyla Elif Sade
- Department of Cardiology, University of Baskent, Yukarı Bahçelievler, Mareşal Fevzi Çakmak Cd. No: 45, 06490 Çankaya/Ankara, Turkey
| | - Jose Luis Zamorano
- Department of Cardiology, Ramon Y Cajal University Hospital, M-607, 9, 100, 28034 Madrid, Spain
| | - Natallia Maroz-Vadalazhskaya
- Department of General Practice, Division of Postgraduate Education, Belarusian State Medical University, Dzerzhinski Ave 83, 220083 Minsk, Belarus
| | - Constantinos Anagnostopoulos
- PET-CT Department & Preclinical Imaging Unit, Centre for Experimental Surgery, Clinical and Translational Research, Biomedical Research Foundation Academy of Athens, 4 Soranou Ephessiou Street, 115 27 Athens, Greece
| | - Filipe Macedo
- Cardiology Department, S João University Hospital, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal
| | - Juhani Knuuti
- Turku PET Centre, Turku University Hospital and University of Turku, c/o Turku University Hospital, Kiinamyllynkatu 4-8, 20520 Turku, Finland
| | - Thor Edvardsen
- Department of Cardiology, Oslo University Hospital, Rikshospitalet, Kirkeveien 166, 0450 Oslo, Norway
- Institute of Clinical Medicine, University of Oslo, Klaus Torgårds vei 3, 0372 Oslo, Norway
| | - Bernard Cosyns
- Centrum voor Hart en Vaatziekten, Universtair Ziekenhuis Brussel, Av. du Laerbeek 101, 1090 Bruxelles, Belgium
- In Vivo Molecular and Cellular Imaging Center, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Jette, Belgium
| | - Steffen E Petersen
- Barts Heart Center, St. Bartholomew's Hospital, West Smithfield, W Smithfield, London EC1A 7BE, UK
- NIHR Barts Biomedical Research Centre, William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK
| | - Julien Magne
- Inserm Unit 1094 and IRD, Faculty of Medicine, Limoges University, 2 rue du Dr Marcland, 87025 Limoges, France
- Centre of Epidemiology, Biostatistic and Methodology of Research, University Hospital, Limoges, 2 Av. Martin Luther King, 87000 Limoges, France
- Department of Cardiology, Dupuytren-2 University Hospital, 16 rue Bernard Descottes, 87042 Limoges, France
| | - Cecile Laroche
- The European Society of Cardiology, The European Heart House, Sophia Antipolis Cedex, 2035 Rte des Colles, 06410 Biot, France
| | - Clara Berlè
- The European Society of Cardiology, The European Heart House, Sophia Antipolis Cedex, 2035 Rte des Colles, 06410 Biot, France
| | - Bogdan A Popescu
- Department of Cardiology, University of Medicine and Pharmacy 'Carol Davila', Euroecolab, Emergency Institute for Cardiovascular Diseases 'Prof. Dr. C. C. Iliescu', Bulevardul Eroii Sanitari 8, 050474 București, Romania
| | - Victoria Delgado
- Department of Cardiology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
- Heart Institute, Hospital University Germans Trias i Pujol, Carretera de Canyet, s/n, 08916, Badalona, Barcelona, Spain
| | | |
Collapse
|
3
|
Liga R, Gimelli A. Radial artery access for invasive coronary angiography: Is going distal the new frontier? Int J Cardiol 2021; 349:46-47. [PMID: 34856295 DOI: 10.1016/j.ijcard.2021.11.064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/23/2021] [Accepted: 11/26/2021] [Indexed: 11/05/2022]
Affiliation(s)
- Riccardo Liga
- University of Pisa, Pisa, Italy.; Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy
| | | |
Collapse
|
4
|
Hourqueig M, Bouzille G, Mirabel M, Huttin O, Damy T, Labombarda F, Eicher JC, Charron P, Habib G, Réant P, Hagège A, Donal E. Hypertrophic cardiomyopathies requiring more monitoring for less atrial fibrillation-related complications: a clustering analysis based on the French registry on hypertrophic cardiomyopathy (REMY). Clin Res Cardiol 2021; 111:163-174. [PMID: 34043053 DOI: 10.1007/s00392-020-01797-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/03/2020] [Accepted: 12/16/2020] [Indexed: 11/25/2022]
Abstract
AIMS Defining the risk of atrial fibrillation (AF) in hypertrophic cardiomyopathy (HCM) patients is an important clinical and prognostic challenge. The aim of this study is to determine HCM phenogroups with different risk of AF occurrence at 5 years. METHODS AND RESULTS We applied retrospectively the Bayesian method, which can analyze a large number of variables, to differentiate phenogroups of patients with different risks of AF and prognoses across a French prospective on-going hospital-based registry of adult HCM patients (REMY). Clinical and imaging data were prospectively recorded, and patients were followed for 5 years. A total of 1431 HCM patients were recruited, including 1275 analyzed in the present study after exclusion criteria. The population included 412 women, 369 patients with obstructive HCM, and 252 implanted with an ICD. AF occurred in 167 (11.6%) patients during the 5 year follow-up. Three phenogroups were defined according to their common clinical and echocardiographic characteristics. Patients at the highest risk were oldest, more often female, with more frequent comorbidities, anteroposterior diameter of the left atrium was significantly greater, with diastolic dysfunction, outflow-tract obstruction, and mitral valve abnormality, and presented higher pulmonary artery pressure and/or right-ventricular dysfunction. These also had a higher risk of all-cause hospitalizations and death. CONCLUSION Based on a clustering analysis, three phenogroups of HCM according to the risk of AF occurrence can be identified. It can indicate which patients should be more monitored and/or treated, particular to prevent the risk of stroke.
Collapse
Affiliation(s)
- Marion Hourqueig
- Service de Cardiologie-Hôpital Pontchaillou, Univ Rennes, CHU Rennes, Inserm, LTSI-UMR 1099, F-35000, Rennes, France
| | - Guillaume Bouzille
- Service de Cardiologie-Hôpital Pontchaillou, Univ Rennes, CHU Rennes, Inserm, LTSI-UMR 1099, F-35000, Rennes, France
| | - Mariana Mirabel
- Cardio-Oncology, Assistance Publique-Hôpitaux de Paris-Centre Université de Paris, University of Paris, Paris, France
| | - Olivier Huttin
- Cardiology Department, CHU de Nancy, Hopitaux de Brabois, Nancy, France
| | - Thibaud Damy
- IMRB and Cardiology Department, Assistance Publique-Hopitaux de Paris, Hopital Henri-Mondor, GRC Amyloid Research Institute, 94000, Creteil, France
| | - Fabien Labombarda
- Cardiology Department, CHU de Caen, Hopital Cote de Nacre, Caen, France
| | | | - Philippe Charron
- Cardiology Department, Assistance Publique-Hôpitaux de Paris, APHP; Hôpital Pitié-Salpêtrière, Paris, France.,Sorbonne Université, INSERM, UMR_S 1166 and ICAN Institute for Cardiometabolism and Nutrition, Paris, France
| | - Gilbert Habib
- Cardiology Department, Assistance Publique-Hopitaux de Marseille, Hopital La Timone, Marseille, France
| | - Patricia Réant
- Cardiology Department, CHU de Bordeaux, Hopital du Haut Leveque, University de Bordeaux, INSERM 1045, IHU Lyric, CIC 1401, Pessac, France
| | - Albert Hagège
- Cardiology Department, CHU de Nancy, Hopitaux de Brabois, Nancy, France
| | - Erwan Donal
- Service de Cardiologie-Hôpital Pontchaillou, Univ Rennes, CHU Rennes, Inserm, LTSI-UMR 1099, F-35000, Rennes, France.
| | | |
Collapse
|
5
|
The role of point of care ultrasound in radiology department: update and prospective. A statement of Italian college ultrasound. Radiol Med 2020; 126:636-641. [PMID: 33146845 DOI: 10.1007/s11547-020-01301-z] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2020] [Accepted: 10/20/2020] [Indexed: 02/07/2023]
Abstract
Ultrasound, in its new point-of-care conception, has been called the stethoscope of the future. Goal-directed bedside ultrasound examination, performed by a healthcare provider to answer a specific diagnostic question or guide an invasive procedure, is currently revolutionizing medical practice. It is used by various specialties in multiple clinical contexts for procedural, diagnostic, and screening applications. Point-of-care ultrasound is also a strategic technique in clinical radiology; it brings the radiologist closer to the patient (in interaction and understanding) like interventional and angiography procedures and, as an integrative imaging modality, is a vital radiological tool for decision-making in many situations. In this commentary, we present our observations on the use of ultrasound, in a sincere appeal to refrain from omitting ultrasound as a diagnostic technique in this era of deep professional change, in which radiologists must return to being a true clinical semiologist.
Collapse
|
6
|
Peultier A, Venetsanos D, Rashid I, Severens JL, Redekop WK. European survey on acute coronary syndrome diagnosis and revascularisation treatment: Assessing differences in reported clinical practice with a focus on strategies for specific patient cases. J Eval Clin Pract 2020; 26:1457-1466. [PMID: 31994256 PMCID: PMC7587003 DOI: 10.1111/jep.13333] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/08/2019] [Revised: 11/21/2019] [Accepted: 11/22/2019] [Indexed: 12/20/2022]
Abstract
RATIONALE, AIMS, AND OBJECTIVES While different imaging and treatment options are available in acute coronary syndrome (ACS) care, there is a lack of data regarding their use across Europe. We examined the diagnostic and treatment strategies in patients with known or suspected ACS as reported by physicians and identified variations in responses across European countries and geographical areas. METHOD A web-based clinician survey focusing on ACS imaging and revascularization treatments was circulated through email distribution lists and websites of European professional societies in the field of cardiology. We collected information on respondents' clinical setting and specialty. Reported percentages of patients receiving imaging or treatment modalities and percentages of clinicians reporting to use modalities in a range of clinical scenarios were analyzed. Statistical comparisons were performed. RESULTS In total, 69 responses were received (Sweden [n = 20], United Kingdom [n = 16], Northern/Western Europe [n = 17], Southern Europe [n = 9], and Central Europe [n = 7]). Considerable variations between geographical areas were seen in terms of reported diagnostic modalities and treatment strategies. For example, when presented with the scenario of a theoretical 45-year-old smoking female with a suspected ACS, 56% of UK clinicians reported to use coronary computed tomography angiography, compared to only 10% of Swedish clinicians (P = .002). Large variations were observed regarding the reported use of fractional flow reserve by physicians for non-culprit lesions during invasive management of myocardial infarction patients (44% in Sweden, 31% in the United Kingdom, and 30% in Northern/Western Europe vs non-use in Central and Southern Europe). CONCLUSIONS In this survey, respondents reported different diagnostic and treatment strategies in ACS care. These variations seem to have geographic components. Larger studies or real world data are needed to verify these observations and investigate their causes. More research is needed to compare the quality and efficiency of ACS care across countries and explore pathways for improvement.
Collapse
Affiliation(s)
- Anne‐Claire Peultier
- Health Technology Assessment, Erasmus School of Health Policy and ManagementErasmus University RotterdamRotterdamThe Netherlands
| | - Dimitrios Venetsanos
- Coronary Artery and Vascular Disease, Heart and Vascular Theme, Department of MedicineKarolinska Institute and Karolinska University HospitalStockholmSweden
| | - Imran Rashid
- School of Biomedical Engineering and Imaging SciencesKing's College LondonLondonUK
- Case Cardiovascular Research InstituteCase Western Reserve UniversityClevelandOhio
| | - Johan L. Severens
- Health Technology Assessment, Erasmus School of Health Policy and ManagementErasmus University RotterdamRotterdamThe Netherlands
- Institute for Medical Technology AssessmentErasmus University RotterdamRotterdamThe Netherlands
| | - William K. Redekop
- Health Technology Assessment, Erasmus School of Health Policy and ManagementErasmus University RotterdamRotterdamThe Netherlands
- Institute for Medical Technology AssessmentErasmus University RotterdamRotterdamThe Netherlands
| |
Collapse
|
7
|
Lorenzoni V, Bellelli S, Caselli C, Knuuti J, Underwood SR, Neglia D, Turchetti G. Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study. THE EUROPEAN JOURNAL OF HEALTH ECONOMICS : HEPAC : HEALTH ECONOMICS IN PREVENTION AND CARE 2019; 20:1437-1449. [PMID: 31410670 PMCID: PMC6856023 DOI: 10.1007/s10198-019-01096-5] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 01/31/2019] [Accepted: 07/31/2019] [Indexed: 06/10/2023]
Abstract
AIM This study aimed at evaluating the cost-effectiveness of different non-invasive imaging-guided strategies for the diagnosis of obstructive coronary artery disease (CAD) in a European population of patients from the Evaluation of Integrated Cardiac Imaging in Ischemic Heart Disease (EVINCI) study. METHODS AND RESULTS Cost-effectiveness analysis was performed in 350 patients (209 males, mean age 59 ± 9 years) with symptoms of suspected stable CAD undergoing computed tomography coronary angiography (CTCA) and at least one cardiac imaging stress-test prior to invasive coronary angiography (ICA) and in whom imaging exams were analysed at dedicated core laboratories. Stand-alone stress-tests or combined non-invasive strategies, when the first exam was uncertain, were compared. The diagnostic end-point was obstructive CAD defined as > 50% stenosis at quantitative ICA in the left main or at least one major coronary vessel. Effectiveness was defined as the percentage of correct diagnosis (cd) and costs were calculated using country-specific reimbursements. Incremental cost-effectiveness ratios (ICERs) were obtained using per-patient data and considering "no-imaging" as reference. The overall prevalence of obstructive CAD was 28%. Strategies combining CTCA followed by stress ECHO, SPECT, PET, or stress CMR followed by CTCA, were all cost-effective. ICERs values indicated cost saving from - 969€/cd for CMR-CTCA to - 1490€/cd for CTCA-PET, - 3092€/cd for CTCA-SPECT and - 3776€/cd for CTCA-ECHO. Similarly when considering early revascularization as effectiveness measure. CONCLUSION In patients with suspected stable CAD and low prevalence of disease, combined non-invasive strategies with CTCA and stress-imaging are cost-effective as gatekeepers to ICA and to select candidates for early revascularization.
Collapse
Affiliation(s)
- Valentina Lorenzoni
- Institute of Management, Scuola Superiore Sant'Anna, Piazza Martiri della Libertà n. 33, 56127, Pisa, Italy.
| | - Stefania Bellelli
- Institute of Management, Scuola Superiore Sant'Anna, Piazza Martiri della Libertà n. 33, 56127, Pisa, Italy
| | | | - Juhani Knuuti
- Turku PET Center, University of Turku and Turku University Hospital, Turku, Finland
| | - Stephen Richard Underwood
- Biomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, UK
| | - Danilo Neglia
- Institute of Clinical Physiology, CNR, Pisa, Italy
- Fondazione CNR Regione Toscana G. Monasterio, Pisa, Italy
| | - Giuseppe Turchetti
- Institute of Management, Scuola Superiore Sant'Anna, Piazza Martiri della Libertà n. 33, 56127, Pisa, Italy
| |
Collapse
|
8
|
Abstract
Ultrasound (US) is an important imaging tool and the most commonly used imaging modality worldwide. Although US requires expertise to be performed at the highest quality levels, basic US exams can be learned by most physicians and medical technologists with knowledge of human anatomy and with physical examination skills. The full potential of US is achieved when it is more than a pure “imaging modality”, but instead an integrated clinical, physical, and imaging assessment in which the examiner interacts directly and personally with the patient. Specific diagnostic US knowledge is strongly encouraged for specialist training in clinical disciplines.
Collapse
|
9
|
Scholte AJ, Liga R, van Rosendael AR, Gimelli A, Scholte A. ‘Brainstorm’ at EACVI. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehw677] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
10
|
Affiliation(s)
- Mathivathana Indrajith
- Cardiac Non-Invasive Diagnostics Department, King's College Hospital NHS Foundation Trust, London, UK
| | - Madalina Garbi
- Cardiac Non-Invasive Diagnostics Department, King's College Hospital NHS Foundation Trust, London, UK
| | - Mark J Monaghan
- Cardiac Non-Invasive Diagnostics Department, King's College Hospital NHS Foundation Trust, London, UK
| |
Collapse
|
11
|
Grapsa J, Kunadian V, Capodanno D, Vidal-Perez R, Radu M, Christia P, Efimova A, Windecker S, Lancellotti P, Cosyns B, Donal E, Alexandru Popescu B, Habib G. Joint EACVI HIT/EAPCI young survey/ESC CoT survey: training and education for 'multimodality imaging in structural interventions': the rise of a new sub-specialty? Eur Heart J Cardiovasc Imaging 2016; 17:1432-1433. [PMID: 27628618 DOI: 10.1093/ehjci/jew171] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/16/2016] [Accepted: 07/18/2016] [Indexed: 12/11/2022] Open
Affiliation(s)
- Julia Grapsa
- Department of Cardiology, Royal Brompton Hospital, Imperial College, London, UK
| | - Vijay Kunadian
- Institute of Cellular Medicine, Newcastle University and Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne, UK
| | - Davide Capodanno
- Cardio-Thoracic-Vascular Department, Ferrarotto Hospital, University of Catania, Catania, Italy
| | - Rafael Vidal-Perez
- Department of Cardiology, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain
| | - Maria Radu
- Department of Cardiology, Copenhagen University Hospital, Copenhagen, Denmark
| | | | - Anastasia Efimova
- Department of Radiology, Republican Scientific and Practical Centre of Cardiology, Minsk, Belarus
| | - Stephan Windecker
- Department of Cardiology, Bern University Hospital, Bern, Switzerland
| | - Patrizio Lancellotti
- Departments of Cardiology, Heart Valve Clinic, University of Liège Hospital, GIGA Cardiovascular Sciences, CHU Sart Tilman, Liège, Belgium.,Gruppo Villa Maria Care and Research, Anthea Hospital, Bari, Italy
| | - Bernard Cosyns
- Cardiology Department, CHVZ (Centrum voor Hart en Vaatziekten), Universtaire Ziekenhuis, Brussels, Belgium
| | - Erwan Donal
- Department of Cardiology, University Hospital of Rennes, Rennes, France
| | - Bogdan Alexandru Popescu
- Department of Cardiology, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania
| | - Gilbert Habib
- Department of Cardiology, Hôpital de la Timone, CHU de Marseille, Marseille, France
| |
Collapse
|
12
|
Garbi M, Edvardsen T, Bax J, Petersen SE, McDonagh T, Filippatos G, Lancellotti P. EACVI appropriateness criteria for the use of cardiovascular imaging in heart failure derived from European National Imaging Societies voting. Eur Heart J Cardiovasc Imaging 2016; 17:711-21. [DOI: 10.1093/ehjci/jew081] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/22/2016] [Accepted: 03/26/2016] [Indexed: 01/08/2023] Open
|
13
|
Comentário a «Critérios de adequação para ecocardiografia transtorácica num centro terciário». Rev Port Cardiol 2015; 34:719-22. [DOI: 10.1016/j.repc.2015.10.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
14
|
Galrinho A. Comment on “Appropriate use criteria for transthoracic echocardiography at a tertiary care center”Comment on “Appropriate use criteria for transthoracic echocardiography at a tertiary care center”. REVISTA PORTUGUESA DE CARDIOLOGIA (ENGLISH EDITION) 2015. [DOI: 10.1016/j.repce.2015.10.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
15
|
Lancellotti P, Nchimi A, Delierneux C, Hego A, Gosset C, Gothot A, Jean-Flory Tshibanda L, Oury C. Biological Effects of Cardiac Magnetic Resonance on Human Blood Cells. Circ Cardiovasc Imaging 2015; 8:e003697. [PMID: 26338876 DOI: 10.1161/circimaging.115.003697] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND Cardiac magnetic resonance (CMR) is increasingly used for the diagnosis and management of cardiac diseases. Recent studies have reported immediate post-CMR DNA double-strand breaks in T lymphocytes. We sought to evaluate CMR-induced DNA damage in lymphocytes, alterations of blood cells, and their temporal persistence. METHODS AND RESULTS In 20 prospectively enrolled healthy men (31.4±7.9 years), blood was drawn before and after (1-2 hours, 2 days, 1 month, and 1 year) unenhanced 1.5T CMR. Blood cell counts, cell death, and activation status of lymphocytes, monocytes, neutrophils, and platelets were evaluated. The first 2-hour post-CMR were characterized by a small increase of lymphocyte B and neutrophil counts and a transient drop of total lymphocytes because of a decrease in natural killer cells. Among blood cells, only neutrophils and monocytes displayed slight and transient activation. DNA double-strand breaks in lymphocytes were quantified through flow cytometric analysis of H2AX phosphorylation (γ-H2AX). γ-H2AX intensity in T lymphocytes did not change early after CMR but increased significantly at day 2 ≤1 month before returning to baseline levels of 1-year post-CMR. CONCLUSIONS Unenhanced CMR is associated with minor but significant immediate blood cell alterations or activations figuring inflammatory response, as well as DNA damage in T lymphocytes observed from day 2 until the first month but disappearing at 1-year follow-up. Although further studies are required to definitely state whether CMR can be used safely, our findings already call for caution when it comes to repeat this examination within a month.
Collapse
Affiliation(s)
- Patrizio Lancellotti
- From the Department of Cardiology and Radiology, GIGA-Cardiovascular Sciences (P.L., A.N., C.D., A.H., A.G., L.J.-F.T., C.O.) and Hematology Department, University Hospital Sart Tilman (C.G., A.G.), University of Liège, Liège, Belgium; and Gruppo Villa Maria Care and Research, E.S. Health Science Foundation, Lugo (RA), Italy (P.L.).
| | - Alain Nchimi
- From the Department of Cardiology and Radiology, GIGA-Cardiovascular Sciences (P.L., A.N., C.D., A.H., A.G., L.J.-F.T., C.O.) and Hematology Department, University Hospital Sart Tilman (C.G., A.G.), University of Liège, Liège, Belgium; and Gruppo Villa Maria Care and Research, E.S. Health Science Foundation, Lugo (RA), Italy (P.L.)
| | - Céline Delierneux
- From the Department of Cardiology and Radiology, GIGA-Cardiovascular Sciences (P.L., A.N., C.D., A.H., A.G., L.J.-F.T., C.O.) and Hematology Department, University Hospital Sart Tilman (C.G., A.G.), University of Liège, Liège, Belgium; and Gruppo Villa Maria Care and Research, E.S. Health Science Foundation, Lugo (RA), Italy (P.L.)
| | - Alexandre Hego
- From the Department of Cardiology and Radiology, GIGA-Cardiovascular Sciences (P.L., A.N., C.D., A.H., A.G., L.J.-F.T., C.O.) and Hematology Department, University Hospital Sart Tilman (C.G., A.G.), University of Liège, Liège, Belgium; and Gruppo Villa Maria Care and Research, E.S. Health Science Foundation, Lugo (RA), Italy (P.L.)
| | - Christian Gosset
- From the Department of Cardiology and Radiology, GIGA-Cardiovascular Sciences (P.L., A.N., C.D., A.H., A.G., L.J.-F.T., C.O.) and Hematology Department, University Hospital Sart Tilman (C.G., A.G.), University of Liège, Liège, Belgium; and Gruppo Villa Maria Care and Research, E.S. Health Science Foundation, Lugo (RA), Italy (P.L.)
| | - André Gothot
- From the Department of Cardiology and Radiology, GIGA-Cardiovascular Sciences (P.L., A.N., C.D., A.H., A.G., L.J.-F.T., C.O.) and Hematology Department, University Hospital Sart Tilman (C.G., A.G.), University of Liège, Liège, Belgium; and Gruppo Villa Maria Care and Research, E.S. Health Science Foundation, Lugo (RA), Italy (P.L.)
| | - Luaba Jean-Flory Tshibanda
- From the Department of Cardiology and Radiology, GIGA-Cardiovascular Sciences (P.L., A.N., C.D., A.H., A.G., L.J.-F.T., C.O.) and Hematology Department, University Hospital Sart Tilman (C.G., A.G.), University of Liège, Liège, Belgium; and Gruppo Villa Maria Care and Research, E.S. Health Science Foundation, Lugo (RA), Italy (P.L.)
| | - Cécile Oury
- From the Department of Cardiology and Radiology, GIGA-Cardiovascular Sciences (P.L., A.N., C.D., A.H., A.G., L.J.-F.T., C.O.) and Hematology Department, University Hospital Sart Tilman (C.G., A.G.), University of Liège, Liège, Belgium; and Gruppo Villa Maria Care and Research, E.S. Health Science Foundation, Lugo (RA), Italy (P.L.)
| |
Collapse
|